Industry reports
Editor highlights

Publication dates

Regenerative Medicine Research Reports, April 2014

You might be interested in: medical equipment, stem cell, therapeutics, more »


 

1-10 of 47 reports for Regenerative Medicine
3-D Matrix, Ltd. (7777) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

3-D Matrix, Ltd. (7777) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... D matrix, ltd. (7777) - Pharmaceuticals & healthcare - deals and alliances profile summary3-d matrix, ltd. (3-D matrix) is a privately-held, regenerative medicine company ...

BioTime, Inc. (BTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

BioTime, Inc. (BTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... And manufacture of regenerative medicine and blood plasma volume expanders.. The company is currently developing pur cell lines and associated espan culture media, hystem hydrogels and human embryonic stem ...

ThermoGenesis Corp. (KOOL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ThermoGenesis Corp. (KOOL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2014
  • by Global Data

... In rancho cordova, california, the us. The company seeks to expand its offerings in regenerative medicine, while partnering with other pioneers in the stem cell arena to accelerate worldwide ...

United States Orthobiologics Market Outlook to 2020

United States Orthobiologics Market Outlook to 2020

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Dsm completes acquisition of kensey nash, regenerative medicine company, for us$360 million 416.2 Asset transactions 436.2.1 Biomet completes acquisition of trauma business of depuy orthopaedics ...

Regenerative medicine and Stem cells Partnering Terms and Agreements

Regenerative medicine and Stem cells Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

... By a comprehensive listing of regenerative medicine and stem cells deals, as well as contract documents available in the public domain. Where available, each deal title links via weblink to an online version ...

Sensory Organ Partnering Terms and Agreements

Sensory Organ Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • March 2014
  • by Currentpartnering

... Drug delivery enabling technology equipment genomics natural product oligonucleotide orphan drug peptides processes recombinant dna regenerative ...

Psychiatry Partnering Terms and Agreements

Psychiatry Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • March 2014
  • by Currentpartnering

... Processesproteomicsradio/chemo-therapyrational drug designrecombinant dnaregenerative medicineresearch servicesresearch suppliesrna therapeuticsscreeningsmall moleculessoftware toolsstem cells ...

ProFibrix, BV. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ProFibrix, BV. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... For hemostasis and regenerative medicine markets. Its product under clinical development includes fibrocaps. Profibrix's fibrocaps is used in the treatment of mild to moderate surgical bleeding, severe bleeding ...

CellProthera - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CellProthera - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... To the treatment of mi will be an effective alternative to coronary bypass surgery and stenting. A pioneer in regenerative medicine, the company received support from french authorities, which is evident from ...

CapRegen Limited - Strategic SWOT Analysis Review

CapRegen Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2014
  • by Global Data

... Of making investments in anti-ageing and regenerative medicine markets. Capregen invests in the anti-ageing healthcare technologies through its doctors goldman, klatz's personal contacts which include ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.